2026-2030年全球體外診斷契約製造市場

全球體外診斷契約製造市場預計將從 2025 年到 2030 年成長至 145.864 億美元，預測期內複合年成長率為 13.3%。

本報告對全球體外診斷契約製造市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新市場趨勢和促進因素以及整體市場環境進行了最新分析。推動此市場發展的因素包括：全球慢性病和感染疾病病率的上升、診斷檢測數量的增加、對一站式體外診斷（IVD）契約製造需求的成長以及最佳化營運成本的策略需求。

本研究客觀地結合了一手和二手訊息，包括主要行業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模數據、區域細分分析以及供應商格局。報告還包含歷史數據和預測數據。

本研究指出，未來幾年，生產流程中先進自動化、機器人和數位雙胞胎技術的廣泛應用將是全球體外診斷契約製造市場成長的關鍵促進因素。此外，體外診斷設備的租賃以及就地檢驗和分散式分子檢測模式的加速發展和整合預計也將產生巨大的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析價格敏感度、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 干擾因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 市場展望，2025-2030年

第5章 市場規模與表現

• 2020-2024年全球體外診斷契約製造市場
• 2020-2024 年設備特定細分市場分析
• 服務類型細分市場分析，2020-2024 年
• 2020-2024年基於技術的細分市場分析
• 區域區隔市場分析，2020-2024 年
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球體外診斷契約製造市場
• 地緣政治衝突的影響：全球體外診斷契約製造市場

第7章：五力分析

第8章 市場區隔：依設備

• 比較：按設備
• 體外診斷耗材
• 體外診斷設備或裝置
• 市場機會：依設備分類

第9章 市場區隔：依服務類型

• 比較：依服務類型
• 檢測方法開發
• 製造業
• 其他
• 市場機會：依服務類型分類

第10章 市場區隔：依技術分類

• 比較：按技術
• 免疫檢測
• 分子診斷
• 臨床化學
• 血液學
• 微生物學
• 市場機會：依技術分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 泰國
  • 印尼
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 瑞士
  • 西班牙
  • 義大利
• 世界其他地區（RoW）
  • 巴西
  • 沙烏地阿拉伯
  • 阿根廷
  • UAE
  • 南非
  • 澳洲
  • 以色列
  • 土耳其
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Benchmark Electronics Inc.
• Celestica Inc.
• Cenogenics Corp.
• Flex Ltd.
• Forefront Medical Technology
• Fujirebio Holdings Inc.
• Gerresheimer AG
• Jabil Inc.
• Kimball Electronics Inc.
• Merck KGaA
• Nolato AB
• Plexus Corp.
• Sanmina Corp.
• Sartorius AG
• Thermo Fisher Scientific Inc.

第16章附錄

The global in vitro diagnostics contract manufacturing market is forecasted to grow by USD 14586.4 mn during 2025-2030, accelerating at a CAGR of 13.3% during the forecast period. The report on the global in vitro diagnostics contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising global prevalence of chronic and infectious diseases and growing volume of diagnostic testing, increasing demand for one-stop-shop ivd contract manufacturing, strategic imperative for operational cost optimization.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global in vitro diagnostics contract manufacturing market is segmented as below:

By Device

• IVD consumables
• IVD equipment or instrument

By Service Type

• Assay development
• Manufacturing
• Others

By Technology

• Immunoassays
• Molecular diagnostics
• Clinical chemistry
• Hematology
• Microbiology

Geography

• Asia
• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Switzerland
  • Spain
  • Italy
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the broad adoption of advanced automation, robotics, and digital twin technology in production workflows as one of the prime reasons driving the global in vitro diagnostics contract manufacturing market growth during the next few years. Also, leasing of ivd equipment and acceleration and integration of point-of-care and decentralized molecular testing formats will lead to sizable demand in the market.

The report on the global in vitro diagnostics contract manufacturing market covers the following areas:

• Global in vitro diagnostics contract manufacturing market sizing
• Global in vitro diagnostics contract manufacturing market forecast
• Global in vitro diagnostics contract manufacturing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global in vitro diagnostics contract manufacturing market vendors that include Benchmark Electronics Inc., Celestica Inc., Cenogenics Corp., Flex Ltd., Forefront Medical Technology, Fujirebio Holdings Inc., Gerresheimer AG, HIARC Inc., Invetech, Jabil Inc., Kimball Electronics Inc., Merck KGaA, Nolato AB, Nova Biomedical Corp., Phillips Medisize, Plexus Corp., Sanmina Corp., Sartorius AG, Tecomet Inc., Thermo Fisher Scientific Inc.. Also, the global in vitro diagnostics contract manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Device
  • Executive Summary - Chart on Market Segmentation by Service Type
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global In Vitro Diagnostics Contract Manufacturing Market 2020 - 2024
  • Historic Market Size - Data Table on Global In Vitro Diagnostics Contract Manufacturing Market 2020 - 2024 ($ million)
• 5.2 Device segment analysis 2020 - 2024
  • Historic Market Size - Device Segment 2020 - 2024 ($ million)
• 5.3 Service Type segment analysis 2020 - 2024
  • Historic Market Size - Service Type Segment 2020 - 2024 ($ million)
• 5.4 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global in vitro diagnostics contract manufacturing market
• 6.2 Impact of geopolitical conflicts on global in vitro diagnostics contract manufacturing market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Device

• 8.1 Market segments
• 8.2 Comparison by Device
• 8.3 IVD consumables - Market size and forecast 2025-2030
• 8.4 IVD equipment or instrument - Market size and forecast 2025-2030
• 8.5 Market opportunity by Device
  • Market opportunity by Device ($ million)

9 Market Segmentation by Service Type

• 9.1 Market segments
• 9.2 Comparison by Service Type
• 9.3 Assay development - Market size and forecast 2025-2030
• 9.4 Manufacturing - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by Service Type
  • Market opportunity by Service Type ($ million)

10 Market Segmentation by Technology

• 10.1 Market segments
• 10.2 Comparison by Technology
• 10.3 Immunoassays - Market size and forecast 2025-2030
• 10.4 Molecular diagnostics - Market size and forecast 2025-2030
• 10.5 Clinical chemistry - Market size and forecast 2025-2030
• 10.6 Hematology - Market size and forecast 2025-2030
• 10.7 Microbiology - Market size and forecast 2025-2030
• 10.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 Asia - Market size and forecast 2025-2030
  • 12.3.1 China - Market size and forecast 2025-2030
  • 12.3.2 India - Market size and forecast 2025-2030
  • 12.3.3 Japan - Market size and forecast 2025-2030
  • 12.3.4 South Korea - Market size and forecast 2025-2030
  • 12.3.5 Thailand - Market size and forecast 2025-2030
  • 12.3.6 Indonesia - Market size and forecast 2025-2030
• 12.4 North America - Market size and forecast 2025-2030
  • 12.4.1 US - Market size and forecast 2025-2030
  • 12.4.2 Canada - Market size and forecast 2025-2030
  • 12.4.3 Mexico - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Switzerland - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 Italy - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 Argentina - Market size and forecast 2025-2030
  • 12.6.4 UAE - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Australia - Market size and forecast 2025-2030
  • 12.6.7 Israel - Market size and forecast 2025-2030
  • 12.6.8 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising global prevalence of chronic and infectious diseases and growing volume of diagnostic testing
  • Increasing demand for one-stop-shop IVD contract manufacturing
  • Strategic imperative for operational cost optimization
• 13.2 Market challenges
  • Stringent regulatory disharmony and complex burden of continuous international compliance auditing
  • Escalating intellectual property protection risks and information security vulnerabilities in shared collaborative workflows
  • Volatile global supply chains and raw material deficits at certain regions
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Broad adoption of advanced automation, robotics, and digital twin technology in production workflows
  • Leasing of IVD equipment
  • Acceleration and integration of point-of-care and decentralized molecular testing formats

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Benchmark Electronics Inc.
  • Benchmark Electronics Inc. - Overview
  • Benchmark Electronics Inc. - Business segments
  • Benchmark Electronics Inc. - Key offerings
  • Benchmark Electronics Inc. - Segment focus
  • SWOT
• 15.5 Celestica Inc.
  • Celestica Inc. - Overview
  • Celestica Inc. - Business segments
  • Celestica Inc. - Key offerings
  • Celestica Inc. - Segment focus
  • SWOT
• 15.6 Cenogenics Corp.
  • Cenogenics Corp. - Overview
  • Cenogenics Corp. - Product / Service
  • Cenogenics Corp. - Key offerings
  • SWOT
• 15.7 Flex Ltd.
  • Flex Ltd. - Overview
  • Flex Ltd. - Business segments
  • Flex Ltd. - Key offerings
  • Flex Ltd. - Segment focus
  • SWOT
• 15.8 Forefront Medical Technology
  • Forefront Medical Technology - Overview
  • Forefront Medical Technology - Product / Service
  • Forefront Medical Technology - Key offerings
  • SWOT
• 15.9 Fujirebio Holdings Inc.
  • Fujirebio Holdings Inc. - Overview
  • Fujirebio Holdings Inc. - Product / Service
  • Fujirebio Holdings Inc. - Key offerings
  • SWOT
• 15.10 Gerresheimer AG
  • Gerresheimer AG - Overview
  • Gerresheimer AG - Business segments
  • Gerresheimer AG - Key offerings
  • Gerresheimer AG - Segment focus
  • SWOT
• 15.11 Jabil Inc.
  • Jabil Inc. - Overview
  • Jabil Inc. - Business segments
  • Jabil Inc. - Key offerings
  • Jabil Inc. - Segment focus
  • SWOT
• 15.12 Kimball Electronics Inc.
  • Kimball Electronics Inc. - Overview
  • Kimball Electronics Inc. - Product / Service
  • Kimball Electronics Inc. - Key offerings
  • SWOT
• 15.13 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.14 Nolato AB
  • Nolato AB - Overview
  • Nolato AB - Business segments
  • Nolato AB - Key offerings
  • Nolato AB - Segment focus
  • SWOT
• 15.15 Plexus Corp.
  • Plexus Corp. - Overview
  • Plexus Corp. - Business segments
  • Plexus Corp. - Key offerings
  • Plexus Corp. - Segment focus
  • SWOT
• 15.16 Sanmina Corp.
  • Sanmina Corp. - Overview
  • Sanmina Corp. - Product / Service
  • Sanmina Corp. - Key offerings
  • SWOT
• 15.17 Sartorius AG
  • Sartorius AG - Overview
  • Sartorius AG - Business segments
  • Sartorius AG - Key offerings
  • Sartorius AG - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations